Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PROKIDNEY CORP. | Chief Executive Officer, Director | Employee stock option (right to buy) | 2M | Dec 3, 2023 | Direct | ||
PROKIDNEY CORP. | Chief Executive Officer, Director | Employee stock option (right to buy) | 500K | Sep 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PROK | PROKIDNEY CORP. | Sep 13, 2024 | 1 | $0 | 4 | Sep 16, 2024 | Chief Executive Officer, Director |
PROK | PROKIDNEY CORP. | Dec 3, 2023 | 1 | $0 | 4 | Dec 5, 2023 | Chief Executive Officer, Director |
PROK | PROKIDNEY CORP. | Aug 1, 2023 | 1 | $0 | 4 | Aug 3, 2023 | EVP, Clinical Development |
PROK | PROKIDNEY CORP. | Jul 17, 2023 | 0 | $0 | 3 | Jul 25, 2023 | EVP, Clinical Development |